Fortrea to buy Worldwide Clinical Trials early-phase services unit for $45M all-cash

PUBT · 2d ago
Fortrea to buy Worldwide Clinical Trials early-phase services unit for $45M all-cash
  • Fortrea agreed to buy Worldwide Clinical Trials’ Early Phase Services division in an all-cash deal valued at about USD 45 million.
  • Assets include a 60,000-square-foot GLP bioanalytical lab in Austin, a 200-bed GCP clinical pharmacology unit in San Antonio.
  • Transaction adds in-house large and small molecule bioanalytical capabilities, expanding Fortrea’s North American early-phase capacity.
  • Business will be folded into Fortrea’s Clinical Pharmacology Services unit once the deal closes.
  • Closing remains subject to regulatory and licensing approvals, along with certain services agreements between the companies.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fortrea Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609020700PRIMZONEFULLFEED9819989) on September 02, 2026, and is solely responsible for the information contained therein.